<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Med Care</journal-id><journal-id journal-id-type="iso-abbrev">Med Care</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Medical care</journal-title></journal-title-group><issn pub-type="ppub">0025-7079</issn><issn pub-type="epub">1537-1948</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC7083172</article-id><article-id pub-id-type="pmcid-ver">PMC7083172.1</article-id><article-id pub-id-type="pmcaid">7083172</article-id><article-id pub-id-type="pmcaiid">7083172</article-id><article-id pub-id-type="manuscript-id">NIHMS1554887</article-id><article-id pub-id-type="pmid">30629016</article-id><article-id pub-id-type="doi">10.1097/MLR.0000000000001058</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1554887</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1554887</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Evaluation of a Medicaid Lock-in Program</article-title><subtitle>Increased Use of Opioid Use Disorder Treatment but No Impact on Opioid Overdose Risk</subtitle></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Naumann</surname><given-names initials="RB">Rebecca B.</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="A1">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Roberts</surname><given-names initials="AW">Andrew W.</given-names></name><degrees>PharmD, PhD</degrees><xref ref-type="aff" rid="A2">&#8224;</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Marshall</surname><given-names initials="SW">Stephen W.</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="A1">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Skinner</surname><given-names initials="AC">Asheley C.</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="A3">&#8225;</xref></contrib></contrib-group><aff id="A1"><label>*</label>Department of Epidemiology and Injury Prevention Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC</aff><aff id="A2"><label>&#8224;</label>Department of Preventive Medicine and Public Health, University of Kansas Medical Center, Kansas City, KS</aff><aff id="A3"><label>&#8225;</label>Duke Clinical Research Institute, Durham, NC</aff><author-notes><corresp id="CR1">Reprints: Rebecca B. Naumann, PhD, Injury Prevention Research Center, University of North Carolina at Chapel Hill, CVS Plaza, Suite 500, 137 East Franklin Street, CB#7505, Chapel Hill, NC 27599. <email>rnaumann@unc.edu</email>.</corresp><fn fn-type="COI-statement" id="FN2"><p id="P28">The authors declare no conflict of interest.</p></fn></author-notes><pub-date pub-type="ppub"><month>3</month><year>2019</year></pub-date><volume>57</volume><issue>3</issue><issue-id pub-id-type="pmc-issue-id">354561</issue-id><fpage>213</fpage><lpage>217</lpage><pub-history><event event-type="nihms-submitted"><date><day>22</day><month>02</month><year>2020</year></date></event><event event-type="pmc-release"><date><day>20</day><month>03</month><year>2020</year></date></event><event event-type="pmc-live"><date><day>20</day><month>03</month><year>2020</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-16 13:25:14.537"><day>16</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1554887.pdf"/><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="correction-forward" xml:lang="en" vol="58" page="293" journal-id="Med Care" journal-id-type="nlm-ta" ext-link-type="pubmed" xlink:href="32049949"><article-title>Evaluation of a Medicaid Lock-in Program: Increased Use of Opioid Use Disorder Treatment but No Impact on Opioid Overdose Risk: Erratum.</article-title><volume>58</volume><issue>3</issue><date><month>3</month><year>2020</year></date><fpage>293</fpage><lpage>293</lpage><source>Med Care</source><pub-id pub-id-type="pmid">32049949</pub-id></related-article><abstract id="ABS1"><sec id="S1"><title>Background:</title><p id="P1"> &#8220;Lock-in&#8221; programs (LIPs) identify beneficiaries demonstrating potential overutilization of opioids, and other controlled substances, and restrict their access to these medications. LIPs are expanding to address the opioid crisis and could be an effective tool for connecting people to opioid use disorder treatment. We examined the immediate and sustained effects of a Medicaid LIP on overdose risk and use of medication-assisted treatment (MAT) for opioid use disorder.</p></sec><sec id="S2"><title>Methods:</title><p id="P2">We analyzed North Carolina Medicaid claims from July 2009 through June 2013. We estimated daily risk differences and ratios of MAT use and overdose during lock-in and following release from the program, compared with periods before program enrollment.</p></sec><sec id="S3"><title>Results:</title><p id="P3">The daily probability of MAT use during lock-in and following release was greater, when compared with a period just before LIP enrollment [daily risk ratios: 1.50, 95% confidence interval (CI): 1.18&#8211;1.91; 2.27, 95% CI: 1.07&#8211;4.80; respectively]. Beneficiaries&#8217; average overdose risk while enrolled in the program and following release was similar to their risk just before enrollment (daily risk ratios: 1.01, 95% CI: 0.79&#8211;1.28; 1.12, 95% CI: 0.82&#8211;1.54; respectively).</p></sec><sec id="S4"><title>Discussion:</title><p id="P4">North Carolina&#8217;s Medicaid LIP was associated with increased use of MAT during enrollment, and this increase was sustained in the year following release from the program. However, we did not observe parallel reductions in overdose risk during lock-in and following release. Identifying facilitators of MAT access and use among this population, as well as potential barriers to overdose reduction are important next steps to ensuring effective LIP design.</p></sec></abstract><kwd-group><kwd>controlled substance</kwd><kwd>lock-in</kwd><kwd>Medicaid</kwd><kwd>opioid</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>